Granted Patent
B2
US 8,653,095 · App. 13/135,868 · Granted Feb 18, 2014
Small molecules with antimalarial activity
Assignee:
Radix Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention provides new chemical compositions with desirable biological activity and toxicity profiles for the enhanced treatment of malaria.
Claims (2)
1. A method for the treatment of malaria comprising administering to a subject a therapeutically effective amount of a compound having the Formula B:
Or a compound having the Formula C:
Assignments (1)
CONFIRMATORY LICENSE
Recorded Sep 12, 2011
From: RADIX PHARMACEUTICALS, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026908/0646 →
Continuity (1)